23-Sep-2025 Tech innovations mark halfway point of Yao’s $1.1 million grant University of Tennessee at Knoxville Big Yao, Dan Doulet Early Career Assistant Professor in the Department of Industrial and Systems Engineering at the University of Tennessee, Knoxville, is part of a research team developing a physics-informed machine learning system to personalize atrial fibrillation (AF) ablation procedures. Their 3D heart simulation model predicts electrical signal spread, optimizing sequential treatments and improving clinical relevance through collaboration with medical professionals, aiming for better outcomes in AF patients.
23-Sep-2025 Scientists visualize atomic structures in moiré materials DOE/Oak Ridge National Laboratory Researchers with the Department of Energy’s Oak Ridge National Laboratory and the University of Tennessee, Knoxville, have created an innovative method to visualize and analyze atomic structures within specially designed, ultrathin bilayer 2D materials. When precisely aligned at an angle, these materials exhibit unique properties that could lead to advancements in quantum computing, superconductors and ultraefficient electronics. Journal Nano Letters
23-Sep-2025 10 years, 10,000 lives: Mayo experts highlight the journey and future of proton beam and particle therapy at Mayo Clinic Mayo Clinic A decade after opening, the Mayo Clinic Proton Therapy Program in Rochester, Minnesota, has treated 10,000 patients. Annually, the program treats 30%–40% more patients than most comparable centers in the country. And, with new technology and facility expansions, it will soon be able to treat nearly 75% more patients each year with even more precise and effective therapies.
22-Sep-2025 Huntsman Cancer Institute Discovery Innovations Fall 2025 Huntsman Cancer Institute Huntsman Cancer Institute's Discovery Innovations showcase the latest advances in cancer treatment, research, and prevention. These achievements demonstrate the progress being made in ending cancer as we know it.
22-Sep-2025 Psychedelics in the treatment of anorexia – a new pilot study Lund University Anorexia nervosa is a serious psychiatric disorder for which there are limited treatment options, and it has one of the highest mortality rates of any psychiatric diagnosis. A pilot study is now underway at Lund University in Sweden, where researchers are investigating whether psychedelic drugs have an effect on young patients with the disorder. Funder Norrsken Mind
22-Sep-2025 Practice Environment Scale receives national endorsement University of Pennsylvania School of Nursing Penn Nursing’s Center for Health Outcomes and Policy Research (CHOPR) is proud to announce that the Practice Environment Scale – Five-Item Composite (PES-5) – has been officially endorsed as a national healthcare quality measure. This endorsement by the Partnership for Quality Measurement (PQM) reflects the PES-5’s scientific rigor, usability, and potential to advance equitable, high-quality healthcare.
22-Sep-2025 A green future for poinsettia Aarhus University New research paves the way for sustainable production of the iconic poinsettia, without bacteria and without heavy manual labour.
22-Sep-2025 Why women bear the burden of dementia: Unraveling the sex gap Texas A&M University Groundbreaking research sheds light on why women are disproportionately affected by dementia — and points to promising new avenues in personalized care. Journal Brain Behavior and Immunity
22-Sep-2025 ETRI ushers in an era of realistic remote collaboration National Research Council of Science & Technology Korean researchers have unveiled next-generation remote collaboration technology that enables users to meet face-to-face and even shake hands in real time with their counterparts as if they were in the same room. Electronics and Telecommunications Research Institute (ETRI) announced that it has publicly introduced for the first time "telepresence augmentation technology for eXtended Reality (XR) environments” which can precisely reproduce facial expressions, gazes, and even handshakes. Funder Ministry of Science and ICT
22-Sep-2025 Blood test detects early-onset Alzheimer's as early as 24 years old BGI Genomics Although Alzheimer's disease is considered an illness of old age, a new study shows blood biomarkers can identify the risk for early-onset Alzheimer's, which develops before the age of 65, as early as age 24.Early detection and prevention remain crucial in managing early-onset Alzheimer's. With modern research and new technologies, doctors can now identify warning signs years, even decades, before symptoms appear.
